GlassScriptPhysician profile
Michelle Lynn Hurst
NPI 1265044093
$2,507.11
in general payments reported to CMS, 2019-2025
20 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $619 · 2022: $673 · 2023: $562 · 2024: $324 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $511.26 | 2021-2025 | |
| Exeltis, USA INC. | $457.84 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $395.32 | 2021-2025 | |
| Astellas Pharma US INC | $180.29 | 2022-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $173.76 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $113.03 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $108.09 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $98.09 | 2021-2022 | |
| Shield Therapeutics INC | $80.31 | 2024 | |
| Millicent US INC | $77.67 | 2025 | Femlyv, Intrarosa |
| Evofem Biosciences, INC. | $43.59 | 2022-2023 | Phexxi |
| Agile Therapeutics, INC. | $42.09 | 2021 | |
| Therapeuticsmd, INC. | $38.85 | 2022 | |
| Avion Pharmaceuticals | $38.14 | 2022-2023 | Balcoltra |
| Organon LLC | $37.30 | 2022-2023 | Nexplanon |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $32.63 | 2021-2022 | |
| Hologic Sales and Service, LLC | $30.11 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Sage Therapeutics, LLC | $17.14 | 2021 | |
| Merck Sharp & Dohme LLC | $16.41 | 2021 | |
| Novo Nordisk INC | $15.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Hurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.